about
Biological and Pharmacological Aspects of the NK1-ReceptorThe DC-HIL/syndecan-4 pathway inhibits human allogeneic T-cell responsesIdentification of valid reference genes for gene expression studies of human stomach cancer by reverse transcription-qPCRDC-HIL/glycoprotein Nmb promotes growth of melanoma in mice by inhibiting the activation of tumor-reactive T cellsDepleting syndecan-4+ T lymphocytes using toxin-bearing dendritic cell-associated heparan sulfate proteoglycan-dependent integrin ligand: a new opportunity for treating activated T cell-driven diseaseSézary syndrome cells overexpress syndecan-4 bearing distinct heparan sulfate moieties that suppress T-cell activation by binding DC-HIL and trapping TGF-beta on the cell surfaceOsteoactivin/HGFIN: is it a tumor suppressor or mediator of metastasis in breast cancer?Melanoma-derived conditioned media efficiently induce the differentiation of monocytes to macrophages that display a highly invasive gene signature.Breast cancer stem cells, pathways and therapeutic perspectives 2011.Glycoprotein non-metastatic b (GPNMB): A metastatic mediator and emerging therapeutic target in cancer.Breast cancer biology: the multifaceted roles of mesenchymal stem cells.Gpnmb is a melanosome-associated glycoprotein that contributes to melanocyte/keratinocyte adhesion in a RGD-dependent fashion.Osteoactivin Promotes Migration of Oral Squamous Cell Carcinomas.Glycoprotein transmembrane nmb: an androgen-downregulated gene attenuates cell invasion and tumorigenesis in prostate carcinoma cells.The DC-HIL ligand syndecan-4 is a negative regulator of T-cell allo-reactivity responsible for graft-versus-host disease.Osteoactivin regulates head and neck squamous cell carcinoma invasion by modulating matrix metalloproteases.GPNMB enhances bone regeneration by promoting angiogenesis and osteogenesis: potential role for tissue engineering bone.
P2860
Q26784074-D3B34BB6-CC54-40B3-993A-E9CE2C33CB2AQ28114771-E2385C62-176B-45DD-817E-436845A339C7Q33589557-788C6AE1-68CE-4BCC-B2CD-F81EF7ECDD4BQ34001061-C8FBD4B5-1D00-4DAC-AF46-BF133A0468AFQ34235950-5261A699-A23F-458C-B2BC-9812373D2F46Q34754395-205BACE4-EF24-429B-87FD-73C29B3C9A07Q36465274-3D423F48-E3B5-46F2-8B90-8E27E1D186FCQ36738000-C4FB2243-30E1-4724-A751-A0D9182EC8A0Q36946326-A61A053D-83EC-488A-BB5F-65EC4D96B74EQ37014479-9458AD84-9FA2-4904-B8AF-970EFDD57FB3Q37111274-6B1B2D19-27E5-46FD-9A05-6C3037407F9AQ37413798-D875D8CE-4D2E-4EC6-825F-569365026725Q38814412-20F25D35-A92E-4E1B-950C-6CCD39703B11Q39404086-FFF0C8A5-0310-4325-9B56-E15788EAF39EQ45230468-503395FE-9FF3-45B8-9629-C51648A36075Q48125956-F684D7FC-E2F2-406B-A771-62B8EC665004Q50883871-583C5331-6719-4E49-9210-5F6CEE0617E9
P2860
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年学术文章
@wuu
2007年学术文章
@zh-cn
2007年学术文章
@zh-hans
2007年学术文章
@zh-my
2007年学术文章
@zh-sg
2007年學術文章
@yue
2007年學術文章
@zh
2007年學術文章
@zh-hant
name
Role of human HGFIN/nmb in breast cancer
@ast
Role of human HGFIN/nmb in breast cancer
@en
type
label
Role of human HGFIN/nmb in breast cancer
@ast
Role of human HGFIN/nmb in breast cancer
@en
prefLabel
Role of human HGFIN/nmb in breast cancer
@ast
Role of human HGFIN/nmb in breast cancer
@en
P2093
P2860
P356
P1476
Role of human HGFIN/nmb in breast cancer
@en
P2093
Margaret Bryan
Meera Hameed
Pranela Rameshwar
Prem S Patel
Rebecca L Metz
P2860
P2888
P356
10.1186/BCR1764
P577
2007-01-01T00:00:00Z
P5875
P6179
1022380638